Psychiatry and Neurology, Neurology · Las Vegas, NV
NPI
1700868155
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5115 S Durango Dr
Las Vegas, NV, 89113
Phone (320) 333-0789
Groups this clinician bills Medicare through
Medicare paid, 2024
$180K
3,358 services
Medicare patients, 2024
380
Average age 70
Drug cost, 2024
$1.4M
2,922 prescriptions
Company payments, 2025
$12K
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin C Xie was code 99214 (office e&m - established), 672 times for 300 patients. In total Kevin C Xie billed 3,358 services in 26 codes, and Medicare paid $180K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 672 | 300 | $90.06 | $61K |
| 99204 Office E&M - New | Office | 157 | 157 | $109.90 | $17K |
| 95886 Electrical Nerve Conductivity | Office | 134 | 66 | $73.00 | $9,782 |
| 95816 Neurologic | Office | 99 | 98 | $305.78 | $30K |
| 95819 Neurologic | Office | 98 | 97 | $350.47 | $34K |
| 95909 Electrical Nerve Conductivity | Office | 32 | 31 | $98.71 | $3,159 |
| 99215 Office E&M - Established | Office | 20 | 20 | $140.21 | $2,804 |
| 95911 Electrical Nerve Conductivity | Office | 18 | 18 | $139.71 | $2,515 |
| 95910 Electrical Nerve Conductivity | Office | 17 | 17 | $108.33 | $1,842 |
| 99205 Office E&M - New | Office | 13 | 13 | $142.26 | $1,849 |
By year: 2022 $137K for 1,673 services; 2023 $160K for 2,279 services; 2024 $180K for 3,358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin C Xie prescribed most often to Medicare patients was Levetiracetam, with 321 prescriptions and refills. In total Kevin C Xie wrote 2,922 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 321 | 480 | 58 | $9,468 |
| Lacosamide Generic | 219 | 245 | 31 | $22K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 164 | 308 | 39 | $1,661 |
| Donepezil Hcl Generic | 138 | 265 | 37 | $916 |
| Lamotrigine Generic | 128 | 163 | 21 | $2,480 |
| Trazodone Hcl Generic | 126 | 160 | 23 | $935 |
| Alprazolam Generic | 116 | 128 | 23 | $1,334 |
| Gabapentin Generic | 99 | 122 | 25 | $729 |
| Topiramate Generic | 72 | 118 | 14 | $874 |
| Clonazepam Generic | 71 | 73 | 17 | $534 |
| Oxcarbazepine Generic | 71 | 85 | 11 | $3,360 |
| Briviact Brivaracetam | 70 | 70 | Under 11 | $104K |
| Lorazepam Generic | 61 | 62 | 25 | $625 |
| Quetiapine Fumarate Generic | 49 | 67 | 11 | $1,401 |
| Escitalopram Oxalate Generic | 49 | 83 | 14 | $383 |
Brand drugs: - claims; generic drugs: 2,467 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin C Xie $12K ($12K in general payments such as food, travel and fees) from 44 companies. The largest payer was Argenx US, Inc. with $4,761.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 20 | $4,761 |
| LivaNova USA, Inc. LIVN | 7 | $1,368 |
| Abbvie Inc. ABBV | 33 | $662 |
| UCB, Inc. UCB.BR | 20 | $510 |
| ACADIA Pharmaceuticals Inc ACAD | 26 | $395 |
| Eisai Inc. 4523.T | 19 | $338 |
| SK Life Science, Inc. | 7 | $332 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $325 |
| Janssen Biotech, Inc. JNJ | 10 | $312 |
| Biogen, Inc. BIIB | 13 | $281 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.